If you are on anticoagulant therapy, the thigh may be your best primary site since it tends to bruise less than the abdomen
GLP-1 patients see an average of 14.9% reduction in body weight after 68 weeks
The following table breaks down key characteristics of various GLP-1 RAs, including Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Saxenda, and Victoza, to give a clearer picture of their differences: This table elucidates the Ozempic vs Mounjaro debate, showing Mounjaros unique position with very high efficacy in both weight loss and blood sugar control
The 2-4 week window is not a hard cutoff
Semaglutide (GLP-1 mono-agonist) typically delivers around 14.9% loss at 68 weeks in STEP 1, against roughly 22.5% for tirzepatide 15 mg in SURMOUNT-1 [4]
It shifts fat to a healthier pattern and can keep lean mass, so your waist may shrink while the scale barely moves